Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

RevenueShares Navellier Overall A-100 Fund (RWV)

51.15
Delayed Data
As of Jul 31
 +0.0618 / +0.12%
Today’s Change
47.73
Today|||52-Week Range
58.73
+5.16%
Year-to-Date

Investment Objective

The investment seeks to outperform the total return performance of the Navellier Overall A-100 Index, the fund's benchmark index. The fund attempts to replicate the portfolio of the RevenueShares Navellier Overall A-100 IndexTM (the "underlying index"). The underlying index is constructed by re-weighting the constituent securities of the benchmark index according to the revenue earned by the companies in the benchmark index, subject to certain asset diversification requirements and a maximum 7% per company weighting. The fund will invest at least 80% of its net assets in companies included in the benchmark index. It is non-diversified.

Performance

1 month-0.17% 3 years+17.70%
3 months+3.66% 5 years+15.74%
1 year+15.53% Since inception+16.08%
Data through 08/01/2015

Quote Details

Previous close$51.09
Open day’s range50.54 – 51.49
Net asset value (NAV)51.20 (07/31/2015)
Daily volume1,433
Average volume (3 months)790
Data as of 3:44pm ET, 07/31/2015

Peer Comparisonvs. Mid-cap growth ETFs

 RWVCategory
Performance 5-yr return+15.74%+17.66%
Expense Gross exp ratio1.37%0.49%
Risk 5 year sharpe ratio1.081.18
Net assets$7.7M$1.4B
Average market cap$19.2B$9.6B
Average P/E21.725.9
Dividend / Share--0.15%

Competitors

IWP iShares Russell Mid-Cap Growth ETF
VOT Vanguard Mid-Cap Growth Index Fund ETF S...
PXMG PowerShares Russell Midcap Pure Growth P...

Holdings

Top 5 Sectors
Portfolio weighting
Consumer goods 39.43%
Consumer service 20.60%
Hardware 9.08%
Industrial materials 7.23%
Financial service 5.28%
Top 10 Holdings
Portfolio weighting
UNH UnitedHealth7.12%
ANTM WellPoint7.01%
AAPL Apple6.94%
KR Kroger Co6.90%
TGT Target6.89%
MCK McKesson Corp6.70%
AET Aetna6.06%
GILD Gilead Sciences2.86%
CNC Centene Corp2.11%
BMY Bristol-Myers Squibb1.85%